![Second‐Generation Drug‐Eluting Balloon for Ostial Side Branch Lesions (001‐Bifurcations): Mid‐Term Clinical and Angiographic Results - Vaquerizo - 2016 - Journal of Interventional Cardiology - Wiley Online Library Second‐Generation Drug‐Eluting Balloon for Ostial Side Branch Lesions (001‐Bifurcations): Mid‐Term Clinical and Angiographic Results - Vaquerizo - 2016 - Journal of Interventional Cardiology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a332b29a-7f1d-42db-b34d-a8b8c498359e/joic12292-fig-0003-m.jpg)
Second‐Generation Drug‐Eluting Balloon for Ostial Side Branch Lesions (001‐Bifurcations): Mid‐Term Clinical and Angiographic Results - Vaquerizo - 2016 - Journal of Interventional Cardiology - Wiley Online Library
![Drug-eluting Balloon is Noninferior to Drug-eluting Stent in Patients With In-stent Restenosis | DAIC Drug-eluting Balloon is Noninferior to Drug-eluting Stent in Patients With In-stent Restenosis | DAIC](https://www.dicardiology.com/sites/default/files/styles/content_feed_large_new/public/field/image/BBraun_Sequent-Please-DEB.jpg?itok=pduDJMap)
Drug-eluting Balloon is Noninferior to Drug-eluting Stent in Patients With In-stent Restenosis | DAIC
![Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease](https://www.mdpi.com/diagnostics/diagnostics-12-02207/article_deploy/html/images/diagnostics-12-02207-g001.png)
Diagnostics | Free Full-Text | The Diagnostic Value of Circulating Biomarkers and Role of Drug-Coated Balloons for In-Stent Restenosis in Patients with Peripheral Arterial Disease
![Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology](https://mma.prnewswire.com/media/1923339/Cordis_SocialGraphics_Wave6_1200x628__1.jpg?p=twitter)
Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology
![Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug- Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry) | Circulation: Cardiovascular Interventions Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug- Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry) | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/80557ed8-5adb-451a-86c8-51a43586eee9/circinterventions.121.010868.fig04.jpg)
Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug- Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry) | Circulation: Cardiovascular Interventions
![Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget](https://www.medgadget.com/wp-content/uploads/2022/01/drug-eluting-balloon-market-scaled.jpg)
Drug Eluting Balloon Market Size, Growth, Trends and Forecast to 2028 | Medtronic, Becton, Boston Scientific Corporation | Medgadget
![Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review](https://www.mdpi.com/molecules/molecules-25-04624/article_deploy/html/images/molecules-25-04624-g001.png)
Molecules | Free Full-Text | Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
![Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions](https://www.ahajournals.org/cms/asset/c3616457-38b3-4798-833c-9a67a874b082/circinterventions.121.011569.fig04.jpg)